ABBOTT LABORATORIES Common Stock, Value, Issued
ABBOTT LABORATORIES (ABT) had Common Stock, Value, Issued of $25.35 billion as of 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-04-29
- 2026-03-31: Common Stock, Value, Issued $25.35B.
- 2025-12-31: Common Stock, Value, Issued $25.53B.
- 2025-09-30: Common Stock, Value, Issued $25.41B.
- 2025-06-30: Common Stock, Value, Issued $25.28B.
| Period end | Common Stock, Value, Issued |
|---|---|
| 2026-03-31 | $25.35B 10-Q · filed 2026-04-29 |
| 2025-12-31 | $25.53B 10-Q · filed 2026-04-29 |
| 2025-09-30 | $25.41B 10-Q · filed 2025-10-29 |
| 2025-06-30 | $25.28B 10-Q · filed 2025-07-30 |
| 2025-03-31 | $25.13B 10-Q · filed 2025-04-30 |
| 2024-12-31 | $25.15B 10-K · filed 2026-02-20 |
| 2024-09-30 | $25.02B 10-Q · filed 2024-10-31 |
| 2024-06-30 | $24.86B 10-Q · filed 2024-07-31 |
| 2024-03-31 | $24.73B 10-Q · filed 2024-05-02 |
| 2023-12-31 | $24.87B 10-K · filed 2025-02-21 |
| 2023-09-30 | $24.73B 10-Q · filed 2023-11-01 |
| 2023-06-30 | $24.61B 10-Q · filed 2023-08-03 |
| 2023-03-31 | $24.49B 10-Q · filed 2023-05-04 |
| 2022-12-31 | $24.71B 10-K · filed 2024-02-16 |
| 2022-09-30 | $24.56B 10-Q · filed 2022-11-01 |
| 2022-06-30 | $24.43B 10-Q · filed 2022-08-02 |
| 2022-03-31 | $24.30B 10-Q · filed 2022-05-03 |
| 2021-12-31 | $24.47B 10-K · filed 2023-02-17 |
| 2021-09-30 | $24.29B 10-Q · filed 2021-11-03 |
| 2021-06-30 | $24.15B 10-Q · filed 2021-08-04 |
| 2021-03-31 | $24.02B 10-Q · filed 2021-05-05 |
| 2020-12-31 | $24.14B 10-K · filed 2022-02-18 |
| 2020-09-30 | $24.04B 10-Q · filed 2020-11-04 |
| 2020-06-30 | $23.89B 10-Q · filed 2020-07-29 |
| 2020-03-31 | $23.73B 10-Q · filed 2020-04-29 |
| 2019-12-31 | $23.85B 10-K · filed 2021-02-19 |
| 2019-09-30 | $23.77B 10-Q · filed 2019-10-31 |
| 2019-06-30 | $23.66B 10-Q · filed 2019-07-31 |
| 2019-03-31 | $23.46B 10-Q · filed 2019-05-01 |
| 2018-12-31 | $23.51B 10-K · filed 2020-02-21 |
| 2018-09-30 | $23.43B 10-Q · filed 2018-10-31 |
| 2018-06-30 | $23.32B 10-Q · filed 2018-08-01 |
| 2018-03-31 | $23.22B 10-Q · filed 2018-05-02 |
| 2017-12-31 | $23.21B 10-K · filed 2019-02-22 |
| 2017-09-30 | $23.12B 10-Q · filed 2017-11-02 |
| 2017-06-30 | $23.01B 10-Q · filed 2017-08-02 |
| 2017-03-31 | $22.89B 10-Q · filed 2017-05-03 |
| 2016-12-31 | $13.03B 10-K · filed 2018-02-16 |
| 2016-09-30 | $12.94B 10-Q · filed 2016-11-03 |
| 2016-06-30 | $12.84B 10-Q · filed 2016-08-03 |
| 2016-03-31 | $12.74B 10-Q · filed 2016-05-04 |
| 2015-12-31 | $12.73B 10-K · filed 2017-02-17 |
| 2015-09-30 | $12.64B 10-Q · filed 2015-11-05 |
| 2015-06-30 | $12.57B 10-Q · filed 2015-08-04 |
| 2015-03-31 | $12.46B 10-Q · filed 2015-05-06 |
| 2014-12-31 | $12.38B 10-K · filed 2016-02-19 |
| 2014-09-30 | $12.21B 10-Q · filed 2014-11-06 |
| 2014-06-30 | $12.13B 10-Q · filed 2014-08-05 |
| 2014-03-31 | $12.03B 10-Q · filed 2014-05-07 |
| 2013-12-31 | $12.05B 10-K · filed 2015-02-27 |
| 2012-12-31 | $11.76B 10-K · filed 2014-02-21 |
| 2011-06-30 | $9.01B 10-Q · filed 2011-08-04 |
| 2011-03-31 | $8.84B 10-Q · filed 2011-05-06 |
| 2010-12-31 | $8.74B 10-Q · filed 2011-08-04 |
| 2010-09-30 | $8.62B 10-Q · filed 2010-11-05 |
| 2010-06-30 | $8.50B 10-Q · filed 2010-08-05 |
| 2010-03-31 | $8.41B 10-Q · filed 2010-05-04 |
| 2009-12-31 | $8.26B 10-K · filed 2011-02-18 |
| 2009-09-30 | $8.01B 10-Q · filed 2009-11-06 |
| 2009-06-30 | $7.93B 10-Q · filed 2009-08-07 |
| 2008-12-31 | $7.44B 10-K · filed 2011-02-18 |
| 2007-12-31 | $6.10B 10-K · filed 2010-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |